Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Synthesis of 2-substituted indoles and evaluation of their antibacterial activity and inhibitory effects on the efflux pump of methicillin-resistant Staphylococcus aureus

Suttinun Vicharn, Jitnapa Sirirak, Weerachai Phutdhawong, Thongchai Taechowisan, Waya S. Phutdhawong.




Abstract
Cited by 2 Articles

A series of 2-arylindoles were synthesized and characterized through spectral analysis. Their antibacterial activity and synergistic effect against multidrug-resistant Staphylococcus aureus were pharmacologically studied. 2-(4-Aminophenyl)-1H-indole (4k) showed a potent inhibitory activity at 15.6 μg/ml against Bacillus subtilis ATCC 6633 and Salmonella typhi ATCC 19430. 2-(3-Nitrophenyl)-1H-indole (4j) at 15.6 μg/ml displayed a potent antibacterial activity only against S. typhi ATCC 19430. All the synthesized compounds elicited a synergistic effect against methicillin-resistant S. aureus Sp6, drug resistance, and efflux pump genes strain. 2-(2-Hydroxyphenyl)-1Hindoles 4g, 4j, and 4k were combined with tetracyclines, thereby decreasing the minimum inhibitory concentration of tetracyclines. Molecular docking showed that interaction with key amino acids occurred at the active site of the NorA efflux pump. Prediction of the toxicity using the ADMET study was also reported.

Key words: 2-arylindoles, antibacterial activity, synergistic effects, MRSA efflux inhibitor






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.